Evidence map›Paper›PMID 28287334›Full record

ReviewSmall GTPases2019

Regulation of Rho GTPase activity at the leading edge of migrating cells by p190RhoGAP.

Aurélien Bidaud-Meynard, Fabien Binamé, Valérie Lagrée, Violaine Moreau

Open access · bronzeAbstract readReview
In one paragraph

Review in Small GTPases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  8. Article
  9. p190RhoGAPs, theCells · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aurélien Bidaud-Meynarda Institut National de la Santé et de la Recherche Médicale , Bordeaux , France.
Fabien Binaméa Institut National de la Santé et de la Recherche Médicale , Bordeaux , France.
Valérie Lagréea Institut National de la Santé et de la Recherche Médicale , Bordeaux , France.
Violaine Moreaua Institut National de la Santé et de la Recherche Médicale , Bordeaux , France.
Inserm · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell migration, a key feature of embryonic development, immunity, angiogenesis, and tumor metastasis, is based on the coordinated regulation of actin dynamics and integrin-mediated adhesion. Rho GTPases play a major role in this phenomenon by regulating the onset and maintenance of actin-based protruding structures at cell leading edges (i.e. lamellipodia and filopodia) and contractile structures (i.e., stress fibers) at their trailing edge. While spatio-temporal analysis demonstrated the tight regulation of Rho GTPases at the migration front during cell locomotion, little is known about how the main regulators of Rho GTPase activity, such as GAPs, GEFs and GDIs, play a role in this process. In this review, we focus on a major negative regulator of RhoA, p190RhoGAP-A and its close isoform p190RhoGAP-B, which are necessary for efficient cell migration. Recent studies, including our, demonstrated that p190RhoGAP-A localization and activity undergo a complex regulatory mechanism, accounting for the tight regulation of RhoA, but also other members of the Rho GTPase family, at the cell periphery.

Indexed as

Cell MovementAnimalsGTPase-Activating ProteinsHumansIsoenzymesrho GTP-Binding ProteinsGTPase-Activating ProteinsIsoenzymesrho GTPase-activating proteinrho GTP-Binding Proteinscell migrationGTPase activating proteinslamellipodiap190RhoGAPRho GTPases

Identifiers

PMID28287334
PMCPMC6380285
OpenAlexW2595738190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.